By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Parc scientifique de Luminy
Case 931
Marseille  Cedex  13288  France
Phone: 33-0-491-828282 Fax: 33-0-491-828289


Company News
Buying Spree Continues as Roche (RHHBY) Picks Up Trophos in $540 Million Deal 1/16/2015 5:57:46 AM
Trophos Completes Pivotal Phase II/III Study of Olesoxime in Spinal Muscular Atrophy (SMA) 11/6/2013 10:53:00 AM
Trophos Announces Final Patient Completion of Phase II Proof-of-Concept Study of TRO40303 in Patients Treated for Acute Myocardial Infarction 10/2/2013 10:08:13 AM
Trophos Completes Patient Enrolment in a First Study of Olesoxime in Relapsing Remitting Multiple Sclerosis 8/7/2013 9:05:41 AM
Trophos Launches First Study of Olesoxime in Multiple Sclerosis Patients 3/14/2013 11:48:24 AM
Trophos Announces Positive Interim Review in Pivotal Study of Olesoxime in Spinal Muscular Atrophy 2/28/2013 10:58:04 AM
Trophos Program Boosted by EUR 1 Million Grant for Olesoxime in Progressive Multiple Sclerosis 10/11/2012 10:47:47 AM
Marceline Clementine Appointed Chief Financial Officer of Trophos 9/18/2012 9:31:24 AM
Trophos Announces Conclusion of MitoTarget Consortium, Achieving Advanced Understanding of Neurodegenerative Diseases 7/31/2012 9:04:49 AM
Trophos Appoints JSB-Partners as Global Partnership Advisor 7/23/2012 12:46:22 PM